Results 131 to 140 of about 1,588,155 (297)
ABSTRACT Background H&N Merkel cell carcinoma (MCC) mainly affects elderly patients, yet age‐stratified treatment patterns and outcomes data are scarce. Methods We analyzed 88 consecutive H&N MCC patients (2000–2022) by age (< 75 vs. ≥ 75 years). OS was estimated by Kaplan–Meier analysis and MCC‐specific death with competing‐risks methods (cause ...
Igor Vainer +3 more
wiley +1 more source
Stereotactic Body Radiation Therapy for Head and Neck Cancers With Perineural Spread
ABSTRACT Background Perineural spread (PNS) in head and neck cancer (HNC) is technically challenging due to complex target volumes adjacent to critical organs. Data on stereotactic body radiation therapy (SBRT) for PNS is scarce. Methods This retrospective study included patients treated with SBRT for PNS across two centers in the USA and Canada from ...
Anna K. Lawless +21 more
wiley +1 more source
Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders
Neutrophil-mediated inflammation is a key feature of immune-mediated chronic skin disorders, but the mechanistic understanding of neutrophil involvement in these conditions remains incomplete.
Ludovica Franceschin +6 more
doaj +1 more source
ABSTRACT Background Immunotherapy is increasingly used for head and neck cutaneous squamous cell carcinoma (cSCC) with perineural spread (PNS), though outcomes remain poorly defined. Methods A systematic review was conducted according to PRISMA and MOOSE guidelines.
Jai Paris +4 more
wiley +1 more source
Introduction JAK inhibitors (JAKi) represent a novel therapeutic approach for treating the immune-mediated dermatologic diseases alopecia areata (AA) and atopic dermatitis (AD).
Paola Facheris +10 more
doaj +1 more source
ABSTRACT This multicenter retrospective study evaluated the impact of type 2 diabetes mellitus (DM) on clinical outcomes and immune‐related adverse events (irAEs) in 450 patients with metastatic non‐small cell lung cancer (NSCLC) treated with second‐line nivolumab at 17 centers between 2016 and 2024. Among these patients, 118 (26.2%) had DM.
Emre Çakır +32 more
wiley +1 more source
New advancements in medicine have paved the way for targeted therapies and immune checkpoint inhibitors (ICIs), which have become mainstays of cancer therapy.
Vrinda Madan +5 more
doaj +1 more source
Tumour Antigen‐Specific Antibody Signatures as Diagnostic Biomarkers for Melanoma
ABSTRACT Early detection of melanoma remains challenging, and minimally invasive diagnostic tools are needed to complement imaging and histopathology. Circulating tumour antigen‐specific antibodies (Abs) are promising biomarkers, but their diagnostic value across melanoma stages is not fully established.
Cristina Vico‐Alonso +4 more
wiley +1 more source
Abstract Objective To evaluate the feasibility and accuracy of remote, clinician‐guided biophysical profile (BPP) assessment using a handheld ultrasound device operated by lay users. Methods This prospective, non‐randomized, quasi‐blinded study compared clinician‐guided ultrasound‐based BPP scans performed remotely by lay users using the Pulsenmore ES ...
Anat Pardo +9 more
wiley +1 more source
Abstract Dyspareunia in peri‐ and postmenopausal women is common, clinically consequential, and often undertreated in gynecologic practice. Although genitourinary syndrome of menopause (GSM) is a frequent contributor, intercourse‐related pain may also reflect vestibular, pelvic floor, dermatologic, inflammatory, treatment‐related, and psychosocial ...
Marek Broul +3 more
wiley +1 more source

